Metoclopramide Tablets — Class II drug recall D-0473-2025
Ongoing recall by Teva Pharmaceuticals USA, Inc, reported 2025-07-02, distributed nationwide. Presence of foreign tablets/capsules.
| Recall number | D-0473-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, Inc, Parsippany, NJ, United States |
| Recall initiated | 2025-05-23 |
| Classified | 2025-06-20 |
| Reported by FDA | 2025-07-02 |
| Distributed | Nationwide (US) |
| Quantity | 36,612 cartons |
| NDC | 00093-2203, 00093-2203-01, 00093-2203-05, 00093-2203-10, 00093-2204, 00093-2204-01, 00093-2204-05 |
| Lot numbers | 5420094 |
| Expiration dates | 2027-09-30 |
Product
Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01.
Reason for recall
Presence of foreign tablets/capsules.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0473-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.